• 3D Shell MEAs for Cardiac Organoids: Advancing Electrophysio

  2026-05-01

  This study introduces programmable shell microelectrode arrays (MEAs) that enable high-resolution, 3D spatiotemporal mapping of electrical activity in human cardiac organoids. The technology overcomes longstanding limitations of 2D MEAs, providing new capabilities for disease modeling, pharmacological testing, and proarrhythmia research.

• AP20187: Chemical Inducer of Dimerization for Controlled Cel

  2026-04-30

  AP20187 empowers researchers to achieve precise, reversible regulation of engineered signaling pathways in both cellular and animal models, making it a cornerstone for conditional gene therapy and fusion protein studies. Its high solubility, reproducible performance, and robust troubleshooting options distinguish it from less reliable dimerization reagents.

• Go 6983: Advancing PKC Inhibition in Autism and Cancer Model

  2026-04-30

  Explore how Go 6983, a potent pan-PKC inhibitor, enables groundbreaking research into PKC signaling in both cancer progression and autism-related neurobehavior. This article offers unique insights into mechanistic findings and practical assay considerations.

• Lisinopril Dihydrate (SKU B3290): Reliable ACE Inhibitor for

  2026-04-29

  This article provides scenario-driven, evidence-based guidance for selecting and deploying Lisinopril dihydrate (SKU B3290) in cell viability, proliferation, and cytotoxicity assays. Through real-world Q&A, we address workflow pitfalls, protocol optimization, and vendor reliability—empowering researchers to achieve reproducible, high-sensitivity data. APExBIO’s Lisinopril dihydrate stands out for its quality control, solubility, and validated performance.

• 5hmC’s Context-Dependent Roles in Rice Drought Response

  2026-04-29

  This study provides the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, revealing how its genomic localization and interaction with 5-methylcytosine (5mC) dynamically regulate gene expression during drought stress. The findings establish 5hmC as a key, context-dependent epigenetic mark with implications for plant stress adaptation and crop engineering.

• Cisplatin (A8321): DNA Crosslinking & Apoptosis in Cancer Re

  2026-04-28

  Cisplatin (CDDP) is a gold-standard DNA crosslinking agent driving apoptosis and tumor growth inhibition in cancer research. Its mechanism—inducing DNA damage and activating p53/caspase-dependent pathways—makes it indispensable for cell viability and chemotherapy resistance studies.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-04-28

  Song et al. reveal that murine norovirus co-opts the host membrane protein NINJ1, enabling selective secretion of the viral NS1 protein during infection. This work uncovers a new, caspase-3–dependent mechanism of unconventional viral protein export, with implications for understanding programmed cell death and host-pathogen interactions.

• Cyclosporin A: Mechanisms, Benchmarks, and Assay Integration

  2026-04-27

  Cyclosporin A is a canonical immunosuppressive cyclic undecapeptide that acts by inhibiting calcineurin via cyclophilin binding, potently suppressing T-cell activation. Its validated effects on mitochondrial permeability and cytokine expression make it indispensable for immunology and mitochondrial research. Protocol integration and application boundaries are clarified here.

• X-ray Triggered Caged Doxorubicin Release via Cherenkov Ligh

  2026-04-27

  Yao et al. introduce a nanomicellar platform enabling localized, X-ray-triggered release of caged doxorubicin for chemoradiation. By leveraging Cherenkov-induced optical activation, the system achieves nuclear drug delivery, enhancing tumor eradication while minimizing systemic toxicity.

• Ibuprofen in Cancer Research: Applied Protocols and Assay Op

  2026-04-26

  Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) offers more than anti-inflammatory action—it enables advanced workflows for apoptosis induction and cell cycle arrest in experimental oncology. Discover how APExBIO’s Ibuprofen (A8446) empowers reproducible, data-driven research with practical troubleshooting and enhanced solubility strategies.

• FGF and SHH Pathway Differences in Penile Development Across

  2026-04-25

  This study reveals that divergent expression patterns of Shh, Fgf10, and Fgfr2 underlie distinct mechanisms of prepuce and urethral groove formation during penile development in guinea pigs versus mice. The findings highlight species-specific regulation of the FGF and SHH signaling axes, offering new models for understanding human genital development and congenital anomalies.

• DMG-PEG2000-NH2: Advancing Bioconjugation for Liposomal Drug

  2026-04-24

  Explore how DMG-PEG2000-NH2, a leading NH2-PEG derivative, uniquely enables robust amide bond formation and optimizes lipid nanoparticle drug delivery. This article provides a scientific deep dive into protocol parameters, comparative advantages, and translational insights beyond conventional usage.

• Cefotaxime: Mechanisms and Research Applications in Antimicr

  2026-04-24

  Cefotaxime, a third-generation cephalosporin antibiotic, is vital for elucidating beta-lactamase resistance and modeling both Gram-positive and Gram-negative bacterial infections. Its robust beta-lactamase stability and proven research efficacy make it a gold-standard tool for antimicrobial resistance studies.

• O-GlcNAcylation Links Wnt Signaling and Glycolysis in Bone F

  2026-04-23

  This study uncovers how Wnt-induced O-GlcNAcylation modulates aerobic glycolysis to drive osteoblast differentiation and bone formation. By demonstrating the critical role of O-GlcNAcylation in stabilizing PDK1 and rewiring glucose metabolism, the research provides new mechanistic insight into skeletal anabolism and potential metabolic intervention points.

• Gemcitabine HCl (SKU A1402): Data-Driven Solutions for Tumor

  2026-04-23

  This article addresses persistent challenges in cell viability and cytotoxicity studies, focusing on the use of Gemcitabine HCl (SKU A1402) for reproducible, quantitative results in cancer research. Drawing on validated protocols and recent imaging innovations, it guides researchers toward reliable experimental outcomes using APExBIO's Gemcitabine HCl.

456 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page